Status:
RECRUITING
Transcutaneous Vagus Nerve Stimulation as a Complementary Therapy to Exercise in Chronic Fatigue
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Chronic Fatigue Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic fatigue is enhanced by adapted physical activity (APA) programs. Patients consulting on St Etienne hospital and suffering from fibromyalgia and long Covid benefit from a 4-6 week APA program, ...
Eligibility Criteria
Inclusion
- Patient over 18 years old
- Signature of informed consent
- Confirmed diagnosis of fibromyalgia or long Covid (ACR 2016 criteria and persistent symptoms lasting more than 6 months after a positive RT-PCR test, respectively)
- Persistent fatigue after an exercise rehabilitation program (FSS score \> 36)
- Physical inactivity, i.e. \<150 minutes per week of physical activity
Exclusion
- Pre-existing atrial fibrillation,
- Left ventricular ejection fraction \<40%
- Severe heart failure
- Recent stroke or myocardial infarction (\<6 months)
- Unilateral or bilateral vagotomy
- Pregnancy or breastfeeding
Key Trial Info
Start Date :
October 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06170645
Start Date
October 3 2024
End Date
August 1 2026
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Saint-Etienne
Saint-Etienne, France, 42055